Advanced search
Publication Cover
Epigenomics Volume 1, 2009 - Issue 2
Submit an article Journal homepage
253
Views
0
CrossRef citations to date
0
Altmetric
Review

Epigenetic Signatures In Stem Cells And Cancer Stem Cells

Hector Hernandez-Vargas1 Epigenetics Group, International Agency for Research on Cancer (IARC), 150 cours Albert-Thomas, 69372 Lyon cedex 08, France. View further author information
,
Nino Sincic2 University of Zagreb, Zagreb, CroatiaView further author information
,
Maria Ouzounova1 Epigenetics Group, International Agency for Research on Cancer (IARC), 150 cours Albert-Thomas, 69372 Lyon cedex 08, France. View further author information
&
Zdenko Herceg1 Epigenetics Group, International Agency for Research on Cancer (IARC), 150 cours Albert-Thomas, 69372 Lyon cedex 08, France. Correspondence[email protected]
View further author information
Pages 261-280 | Published online: 03 Dec 2009

Bibliography

  • Bird A : Perceptions of epigenetics.Nature447(7143) , 396–398 (2007).
  • Ledford H : Language: disputed definitions.Nature455(7216) , 1023–1028 (2008).
  • Feinberg AP , OhlssonR, HenikoffS: The epigenetic progenitor origin of human cancer.Nat. Rev. Genet.7(1) , 21–33 (2006).
  • Takahashi K , TanabeK, OhnukiM et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell131(5) , 861–872 (2007).
  • Takahashi K , YamanakaS: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell126(4) , 663–676 (2006).
  • Wernig M , MeissnerA, ForemanR et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.Nature448(7151) , 318–324 (2007).
  • Yu J , HuK, Smuga-OttoK et al.: Human induced pluripotent stem cells free of vector and transgene sequences.Science324(5928) , 797–801 (2009).
  • Yu J , VodyanikMA, Smuga-OttoK et al.: Induced pluripotent stem cell lines derived from human somatic cells.Science318(5858) , 1917–1920 (2007).
  • Park IH , ZhaoR, WestJA et al.: Reprogramming of human somatic cells to pluripotency with defined factors.Nature451(7175) , 141–146 (2008).
  • Maherali N , SridharanR, XieW et al.: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.Cell Stem Cell1(1) , 55–70 (2007).
  • Hajkova P , AncelinK, WaldmannT et al.: Chromatin dynamics during epigenetic reprogramming in the mouse germ line.Nature452(7189) , 877–881 (2008).
  • Shukla V , VaissiereT, HercegZ: Histone acetylation and chromatin signature in stem cell identity and cancer.Mutat. Res.637(1–2) , 1–15 (2008).
  • Visvader JE , IndemanGJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.Nat. Rev. Cancer8(10) , 755–768 (2008).
  • Evans MJ , KaufmanMH: Establishment in culture of pluripotential cells from mouse embryos.Nature292(5819) , 154–156 (1981).
  • Fuchs E , SegreJA: Stem cells: a new lease on life.Cell100(1) , 143–155 (2000).
  • Niwa H : Open conformation chromatin and pluripotency.Gen. Dev.21(21) , 2671–2676 (2007).
  • Cowan CA , AtienzaJ, MeltonDA, EgganK: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells.Science309(5739) , 1369–1373 (2005).
  • Spivakov M , FisherAG: Epigenetic signatures of stem-cell identity.Nat. Rev. Genet.8(4) , 263–271 (2007).
  • Azuara V , PerryP, SauerS et al.: Chromatin signatures of pluripotent cell lines.Nat. Cell Biol.8 , 532–538 (2006).
  • Bibikova M , ChudinE, WuB et al.: Human embryonic stem cells have a unique epigenetic signature.Genome Res.16(9) , 1075–1083 (2006).
  • Bernstein BE , MikkelsenTS, XieX et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells.Cell125(2) , 315–326 (2006).
  • Sparmann A , van Lohuizen M: Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer6(11) , 846–856 (2006).
  • Meshorer E , YellajoshulaD, GeorgeE et al.: Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells.Dev. Cell10(1) , 105–116 (2006).
  • Buszczak M , SpradlingAC: Searching chromatin for stem cell identity.Cell125(2) , 233–236 (2006).
  • Bartova E , KrejciJ, HarnicarovaA, KozubekS: Differentiation of human embryonic stem cells induces condensation of chromosome territories and formation of heterochromatin protein 1 foci.Differentiation76(1) , 24–32 (2008).
  • Bartova E , GaliovaG, KrejciJ et al.: Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation.Dev. Dyn.237(12) , 3690–3702 (2008).
  • Levasseur DN , WangJ, DorschnerMO, StamatoyannopoulosJA, OrkinSH: Oct4 dependence of chromatin structure within the extended NANOG locus in ES cells.Genes Dev.22(5) , 575–580 (2008).
  • Tiwari VK , CopeL, McGarveyKM, OhmJE, BaylinSB: A novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations.Genome Res.18(7) , 1171–1179 (2008).
  • Tiwari VK , McGarveyKM, LicchesiJD et al.: PcG proteins, DNA methylation, and gene repression by chromatin looping.PLoS Biol.6(12) , 2911–2927 (2008).
  • Kouzarides T : Chromatin modifications and their function.Cell128(4) , 693–705 (2007).
  • Strahl BD , AllisCD: The language of covalent histone modifications.Nature403(6765) , 41–45 (2000).
  • Ohm JE , McGarveyKM, YuX et al.: A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.Nat. Genet.39(2) , 237–242 (2007).
  • Pan G , TianS, NieJ et al.: Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells.Cell Stem Cell1(3) , 299–312 (2007).
  • Pasini D , BrackenAP, JensenMR, Lazzerini Denchi E, Helin K: Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J.23(20) , 4061–4071 (2004).
  • Lee TI , JennerRG, BoyerLA et al.: Control of developmental regulators by Polycomb in human embryonic stem cells.Cell125(2) , 301–313 (2006).
  • Boyer LA , PlathK, ZeitlingerJ et al.: Polycomb complexes repress developmental regulators in murine embryonic stem cells.Nature441(7091) , 9–53 (2006).
  • Lee MG , VillaR, TrojerP et al.: Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.Science318(5849) , 447–450 (2007).
  • Lan F , BaylissPE, RinnJL et al.: A histone H3 lysine 27 demethylase regulates animal posterior development.Nature449(7163) , 689–694 (2007).
  • Agger K , CloosPA, ChristensenJ et al.: UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.Nature449(7163) , 731–734 (2007).
  • Sen GL , WebsterDE, BarraganDI, ChangHY, KhavariPA: Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3.Gen. Dev.22(14) , 1865–1870 (2008).
  • Torres-Padilla ME , ParfittDE, KouzaridesT, Zernicka-GoetzM: Histone arginine methylation regulates pluripotency in the early mouse embryo.Nature445(7124) , 214–218 (2007).
  • Henikoff S , AhmadK: Assembly of variant histones into chromatin.Annu. Rev. Cell Dev. Biol.21 , 133–153 (2005).
  • Hake SB , AllisCD: Histone H3 variants and their potential role in indexing mammalian genomes: the ‘H3 barcode hypothesis‘.Proc. Natl Acad. Sci. USA103(17) , 6428–6435 (2006).
  • Santenard A , Torres-PadillaME: Epigenetic reprogramming in mammalian reproduction: contribution from histone variants.Epigenetics4(2) , 80–84 (2009).
  • Dai B , RasmussenTP: Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells.Stem Cells25(10) , 2567–2574 (2007).
  • Rangasamy D , BervenL, RidgwayP, TremethickDJ: Pericentric heterochromatin becomes enriched with H2A.Z during early mammalian development.EMBO J.22(7) , 1599–1607 (2003).
  • Rasmussen TP , MastrangeloMA, EdenA, PehrsonJR, JaenischR: Dynamic relocalization of histone MacroH2A1 from centrosomes to inactive X chromosomes during X inactivation.J. Cell Biol.150(5) , 1189–1198 (2000).
  • Shaw ML , WilliamsEJ, HawesS, SafferyR: Characterisation of histone variant distribution in human embryonic stem cells by transfection of in vitro transcribed mRNA.Mol. Reprod. Dev.76(12) , 1128–1142 (2009).
  • Creyghton MP , MarkoulakiS, LevineSS et al.: H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment.Cell135(4) , 649–661 (2008).
  • Wong LH , RenH, WilliamsE et al.: Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells.Genome Res.19(3) , 404–414 (2009).
  • Bird A : DNA methylation patterns and epigenetic memory.Gen. Dev.16(1) , 6–21 (2002).
  • Monk M , BoubelikM, LehnertS: Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development.Development99(3) , 371–382 (1987).
  • Bernstein BE , MeissnerA, LanderES: The mammalian epigenome.Cell128(4) , 669–681 (2007).
  • Farthing CR , FiczG, NgRK et al.: Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.PLoS Genet.4(6) , E1000116 (2008).
  • Irizarry RA , Ladd-AcostaC, WenB et al.: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.Nat. Genet.41(2) , 178–186 (2009).
  • Reik W : Stability and flexibility of epigenetic gene regulation in mammalian development.Nature447(7143) , 425–432 (2007).
  • Kafri T , ArielM, BrandeisM et al.: Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line.Gen. Dev.6(5) , 705–714 (1992).
  • Freitag M , SelkerEU: Controlling DNA methylation: many roads to one modification.Curr. Opin. Genet. Dev.15(2) , 191–199 (2005).
  • Turek-Plewa J , JagodzinskiPP: The role of mammalian DNA methyltransferases in the regulation of gene expression.Cell. Mol. Biol. Lett.10(4) , 631–647 (2005).
  • Okano M , BellDW, HaberDA, LiE: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.Cell99(3) , 247–257 (1999).
  • Li E , BestorTH, JaenischR: Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.Cell69(6) , 915–926 (1992).
  • Weih F , NitschD, ReikA, SchutzG, BeckerPB: Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo.EMBO J.10(9) , 2559–2567 (1991).
  • Campanero MR , ArmstrongMI, FlemingtonEK: CpG methylation as a mechanism for the regulation of E2F activity.Proc. Natl Acad. Sci. USA97(12) , 6481–6486 (2000).
  • Eden S , HashimshonyT, KeshetI, CedarH, ThorneAW: DNA methylation models histone acetylation.Nature394(6696) , 842 (1998).
  • Bird AP , WolffeAP: Methylation-induced repression – belts, braces and chromatin.Cell99(5) , 451–454 (1999).
  • Bannister AJ , ZegermanP, PartridgeJF et al.: Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.Nature410(6824) , 120–124 (2001).
  • Lachner M , O‘CarrollD, ReaS, MechtlerK, JenuweinT: Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.Nature410(6824) , 116–120 (2001).
  • Golan-Mashiach M , DazardJE, Gerecht-NirS et al.: Design principle of gene expression used by human stem cells: implication for pluripotency.FASEB J.19(1) , 147–149 (2005).
  • Jackson M , KrassowskaA, GilbertN et al.: Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells.Mol. Cell. Biol.24(20) , 8862–8871 (2004).
  • Zvetkova I , ApedaileA, RamsahoyeB et al.: Global hypomethylation of the genome in XX embryonic stem cells.Nat. Genet.37(11) , 1274–1279 (2005).
  • Gangaraju VK , LinH: MicroRNAs: key regulators of stem cells.Nat. Rev. Mol. Cell Biol.10(2) , 116–125 (2009).
  • Wang Y , KeysDN, Au-YoungJK, ChenC: MicroRNAs in embryonic stem cells.J. Cell. Physiol.218(2) , 251–255 (2009).
  • Kim KS , KimJS, LeeMR, JeongHS, KimJ: A study of microRNAs in silico and in vivo: emerging regulators of embryonic stem cells.FEBS J.276(8) , 2140–2149 (2009).
  • Berezikov E , GuryevV, van de Belt J et al.: Phylogenetic shadowing and computational identification of human microRNA genes. Cell120(1) , 21–24 (2005).
  • Bartel DP : MicroRNAs: genomics, biogenesis, mechanism, function.Cell116(2) , 281–297 (2004).
  • John B , EnrightAJ, AravinA et al.: Human microRNA targets.PLoS Biol2(11) , E363 (2004).
  • Griffiths-Jones S : The microRNA registry.Nucleic Acids Res.32(Database issue) , D109–D111 (2004).
  • Landgraf P , RusuM, SheridanR et al.: A mammalian microRNA expression atlas based on small RNA library sequencing.Cell129(7) , 1401–1414 (2007).
  • Ketting RF , FischerSE, BernsteinE et al.: Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.Genes Dev.15(20) , 2654–2659 (2001).
  • Bernstein E , KimSY, CarmellMA et al.: Dicer is essential for mouse development.Nat. Genet.35(3) , 215–217 (2003).
  • Wienholds E , KoudijsMJ, van Eeden FJ, Cuppen E, Plasterk RH: The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat. Genet.35(3) , 217–218 (2003).
  • Sinkkonen L , HugenschmidtT, BerningerP et al.: MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells.Nat. Struct. Mol. Biol.15(3) , 259–267 (2008).
  • Laurent LC , ChenJ, UlitskyI et al.: Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence.Stem Cells26(6) , 1506–1516 (2008).
  • Suh MR , LeeY, KimJY et al.: Human embryonic stem cells express a unique set of microRNAs.Dev. Biol.270(2) , 488–498 (2004).
  • Houbaviy HB , MurrayMF, SharpPA: Embryonic stem cell-specific microRNAs.Dev. Cell5(2) , 351–358 (2003).
  • Singh SK , KagalwalaMN, Parker-ThornburgJ, AdamsH, MajumderS: REST maintains self-renewal and pluripotency of embryonic stem cells.Nature453(7192) , 223–227 (2008).
  • Tay Y , ZhangJ, ThomsonAM, LimB, RigoutsosI: MicroRNAs to NANOG, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation.Nature455(7216) , 1124–1128 (2008).
  • Conaco C , OttoS, HanJJ, MandelG: Reciprocal actions of REST and a microRNA promote neuronal identity.Proc. Natl Acad. Sci. USA103(7) , 2422–2427 (2006).
  • Morin RD , O‘ConnorMD, GriffithM et al.: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.Genome Res.18(4) , 610–621 (2008).
  • Li SS , YuSL, KaoLP et al.: Target identification of microRNAs expressed highly in human embryonic stem cells.J. Cell. Biochem.106(6) , 1020–1030 (2009).
  • Cao H , YangCS, RanaTM: Evolutionary emergence of microRNAs in human embryonic stem cells.PLoS ONE3(7) , E2820 (2008).
  • Bussing I , SlackFJ, GrosshansH: Let-7 microRNAs in development, stem cells and cancer.Trends Mol. Med.14(9) , 400–409 (2008).
  • Benetti R , GonzaloS, JacoI et al.: A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases.Nat. Struct. Mol. Biol.15(9) , 998 (2008).
  • Stingl J , CaldasC: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis.Nat. Rev. Cancer7(10) , 791–799 (2007).
  • Lapidot T , SirardC, VormoorJ et al.: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature367(6464) , 645–648 (1994).
  • Bonnet D , DickJE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat. Med.3(7) , 730–737 (1997).
  • Sirard C , LapidotT, VormoorJ et al.: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.Blood87(4) , 1539–1548 (1996).
  • Kong Y , YoshidaS, SaitoY et al.: CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.Leukemia22(6) , 1207–1213 (2008).
  • Krivtsov AV , ArmstrongSA: MLL translocations, histone modifications and leukaemia stem-cell development.Nature reviews7(11) , 823–833 (2007).
  • Al-Hajj M , WichaMS, Benito-HernandezA, MorrisonSJ, ClarkeMF: Prospective identification of tumorigenic breast cancer cells.Proc. Natl Acad. Sci. USA100(7) , 3983–3988 (2003).
  • Singh SK , HawkinsC, ClarkeID et al.: Identification of human brain tumour initiating cells.Nature432(7015) , 396–401 (2004).
  • Collins AT , BerryPA, HydeC, StowerMJ, MaitlandNJ: Prospective identification of tumorigenic prostate cancer stem cells.Cancer Res.65(23) , 10946–10951 (2005).
  • Fang D , NguyenTK, LeishearK et al.: A tumorigenic subpopulation with stem cell properties in melanomas.Cancer Res.65(20) , 9328–9337 (2005).
  • Schatton T , MurphyGF, FrankNY et al.: Identification of cells initiating human melanomas.Nature451(7176) , 345–349 (2008).
  • Kim CF , JacksonEL, WoolfendenAE et al.: Identification of bronchioalveolar stem cells in normal lung and lung cancer.Cell121(6) , 823–835 (2005).
  • Ma S , ChanKW, HuL et al.: Identification and characterization of tumorigenic liver cancer stem/progenitor cells.Gastroenterology132(7) , 2542–2556 (2007).
  • Yin S , LiJ, HuC et al.: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity.Int. J. Cancer120(7) , 1444–1450 (2007).
  • Ricci-Vitiani L , LombardiDG, PilozziE et al.: Identification and expansion of human colon-cancer-initiating cells.Nature445(7123) , 111–115 (2007).
  • O‘Brien CA , PollettA, GallingerS, DickJE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature445(7123) , 106–110 (2007).
  • Prince ME , SivanandanR, KaczorowskiA et al.: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.Proc. Natl Acad. Sci. USA104(3) , 973–978 (2007).
  • Li C , HeidtDG, DalerbaP et al.: Identification of pancreatic cancer stem cells.Cancer Res.67(3) , 1030–1037 (2007).
  • Ferrandina G , BonannoG, PierelliL et al.: Expression of CD133–1 and CD133–2 in ovarian cancer.Int. J. Gynecol. Cancer18(3) , 506–514 (2008).
  • Zhang S , BalchC, ChanMW et al.: Identification and characterization of ovarian cancer-initiating cells from primary human tumors.Cancer Res.68(11) , 4311–4320 (2008).
  • Fabian A , BarokM, VerebG, SzollosiJ: Die hard: are cancer stem cells the Bruce Willises of tumor biology?Cytometry A75(1) , 67–74 (2009).
  • Barnhart BC , SimonMC: Metastasis and stem cell pathways.Cancer Metastasis Rev.26(2) , 261–271 (2007).
  • Weissman IL : Normal and neoplastic stem cells.Novartis Found. Symp.265 , 35–50; discussion 50–54, 92–97 (2005).
  • Ivanova N , DobrinR, LuR et al.: Dissecting self-renewal in stem cells with RNA interference.Nature442(7102) , 533–538 (2006).
  • Ramalho-Santos M , YoonS, MatsuzakiY, MulliganRC, MeltonDA: ‘Stemness‘: transcriptional profiling of embryonic and adult stem cells.Science298(5593) , 597–600 (2002).
  • Ivanova NB , DimosJT, SchanielC et al.: A stem cell molecular signature.Science298(5593) , 601–604 (2002).
  • Sperger JM , ChenX, DraperJS et al.: Gene-expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.Proc. Natl Acad. Sci. USA100(23) , 13350–13355 (2003).
  • Assou S , Le Carrour T, Tondeur S et al.: A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells25(4) , 961–973 (2007).
  • Muller FJ , LaurentLC, KostkaD et al.: Regulatory networks define phenotypic classes of human stem cell lines.Nature455(7211) , 401–405 (2008).
  • Tanaka TS , KunathT, KimberWL et al.: Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.Genome Res.12(12) , 1921–1928 (2002).
  • Skottman H , MikkolaM, LundinK et al.: Gene expression signatures of seven individual human embryonic stem cell lines.Stem cells23(9) , 1343–1356 (2005).
  • Ben-Porath I , ThomsonMW, CareyVJ et al.: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.Nat. Genet.40(5) , 499–507 (2008).
  • Birnie R , BryceSD, RoomeC et al.: Gene-expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.Genome Biol.9(5) , R83 (2008).
  • Klarmann GJ , HurtEM, MathewsLA et al.: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.Clin. Exp. Metastasis26(5) , 433–446 (2009).
  • Galie M , KonstantinidouG, PeroniD et al.: Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice.Oncogene27(18) , 2542–2551 (2008).
  • Charafe-Jauffret E , GinestierC, IovinoF et al.: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.Cancer Res.69(4) , 1302–1313 (2009).
  • Ke XS , QuY, RostadK et al.: Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.PLoS ONE4(3) , E4687 (2009).
  • Glinsky GV : ‘Stemness‘ genomics law governs clinical behavior of human cancer: implications for decision making in disease management.J. Clin. Oncol.26(17) , 2846–2853 (2008).
  • Yu J , YuJ, RhodesDR et al.: A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.Cancer Res.67(22) , 10657–10663 (2007).
  • Metsuyanim S , Pode-ShakkedN, Schmidt-OttKM et al.: Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes.Stem Cells26(7) , 1808–1817 (2008).
  • Calvisi DF , LaduS, GordenA et al.: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.J. Clin. Invest.117(9) , 2713–2722 (2007).
  • Suzuki K , SuzukiI, LeodolterA et al.: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage.Cancer Cell9(3) , 199–207 (2006).
  • Jones PA , BaylinSB: The fundamental role of epigenetic events in cancer.Nat. Rev. Genet.3(6) , 415–428 (2002).
  • Baylin SB , OhmJE: Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Nat. Rev. Cancer6(2) , 107–116 (2006).
  • Issa JP : CpG island methylator phenotype in cancer.Nat. Rev. Cancer4(12) , 988–993 (2004).
  • Bloushtain-Qimron N , YaoJ, SnyderEL et al.: Cell type-specific DNA methylation patterns in the human breast.Proc. Natl Acad. Sci. USA105(37) , 14076–14081 (2008).
  • Shipitsin M , CampbellLL, ArganiP et al.: Molecular definition of breast tumor heterogeneity.Cancer Cell11(3) , 259–273 (2007).
  • Mohinta S , WuH, ChaurasiaP, WatabeK: Wnt pathway and breast cancer.Front. Biosci.12 , 4020–4033 (2007).
  • Klarmann GJ , DeckerA, FarrarWL: Epigenetic gene silencing in the Wnt pathway in breast cancer.Epigenetics3(2) , 59 (2008).
  • Lindvall C , BuW, WilliamsBO, LiY: Wnt signaling, stem cells, and the cellular origin of breast cancer.Stem Cell Rev.3(2) , 157–168 (2007).
  • Cheng AS , CulhaneAC, ChanMW et al.: Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.Cancer Res.68(6) , 1786–1796 (2008).
  • Calvanese V , HorrilloA, HmadchaA et al.: Cancer genes hypermethylated in human embryonic stem cells.PLoS ONE3(9) , E3294 (2008).
  • Meissner A , MikkelsenTS, GuH et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells.Nature454(7205) , 766–770 (2008).
  • Widschwendter M , FieglH, EgleD et al.: Epigenetic stem cell signature in cancer.Nat. Genet.39(2) , 157–158 (2007).
  • Schuebel K , ChenW, BaylinSB: CIMPle origin for promoter hypermethylation in colorectal cancer?Nat. Genet.38(7) , 738–740 (2006).
  • Brunner AL , JohnsonDS, KimSW et al.: Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver.Genome Res.19(6) , 1044–1056 (2009).
  • Hahn MA , HahnT, LeeDH et al.: Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.Cancer Res.68(24) , 10280–10289 (2008).
  • McGarvey KM , Van Neste L, Cope L et al.: Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. Cancer Res.68(14) , 5753–5759 (2008).
  • Gartel AL , KandelES: RNA interference in cancer.Biomol. Eng.23(1) , 17–34 (2006).
  • Nimmo RA , SlackFJ: An elegant miRror: microRNAs in stem cells, developmental timing and cancer.Chromosoma118(4) , 405–418 (2009).
  • Calin GA , SevignaniC, DumitruCD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc. Natl Acad. Sci. USA101(9) , 2999–3004 (2004).
  • Lu J , GetzG, MiskaEA et al.: MicroRNA expression profiles classify human cancers.Nature435(7043) , 834–838 (2005).
  • Takamizawa J , KonishiH, YanagisawaK et al.: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.Cancer Res.64(11) , 3753–3756 (2004).
  • Thomson JM , NewmanM, ParkerJS et al.: Extensive post-transcriptional regulation of microRNAs and its implications for cancer.Genes Dev.20(16) , 2202–2207 (2006).
  • Lujambio A , CalinGA, VillanuevaA et al.: A microRNA DNA methylation signature for human cancer metastasis.Proc. Natl Acad. Sci. USA105(36) , 13556–13561 (2008).
  • Wang Y , BlellochR: Cell cycle regulation by MicroRNAs in embryonic stem cells.Cancer Res.69(10) , 4093–4096 (2009).
  • Yu F , YaoH, ZhuP et al.: Let-7 regulates self renewal and tumorigenicity of breast cancer cells.Cell131(6) , 1109–1123 (2007).
  • Iorio MV , FerracinM, LiuCG et al.: MicroRNA gene expression deregulation in human breast cancer.Cancer Res.65(16) , 7065–7070 (2005).
  • Shell S , ParkSM, RadjabiAR et al.: Let-7 expression defines two differentiation stages of cancer.Proc. Natl Acad. Sci. USA104(27) , 11400–11405 (2007).
  • Park SM , ShellS, RadjabiAR et al.: Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.Cell Cycle6(21) , 2585–2590 (2007).
  • Shimono Y , ZabalaM, ChoRW et al.: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.Cell138(3) , 592–603 (2009).
  • Su X , GopalakrishnanV, StearnsD et al.: Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.Mol. Cell. Biol.26(5) , 1666–1678 (2006).
  • Purdue MP , DevesaSS, SigurdsonAJ, McGlynnKA: International patterns and trends in testis cancer incidence.Int. J. Cancer115(5) , 822–827 (2005).
  • Bray F , RichiardiL, EkbomA et al.: Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality.Int. J. Cancer118(12) , 3099–3111 (2006).
  • Sokoloff MH , JoyceGF, WiseM: Testis cancer.J. Urol.177(6) , 2030–2041 (2007).
  • van de Geijn GJ , HersmusR, LooijengaLH: Recent developments in testicular germ cell tumor research.Birth Defects Res C Embryo Today87(1) , 96–113 (2009).
  • Bulic-Jakus F , UlamecM, VlahovicM et al.: Of mice and men: teratomas and teratocarcinomas.Coll. Antropol.30(4) , 921–924 (2006).
  • Korkola JE , HeckS, OlshenAB et al.: In vivo differentiation and genomic evolution in adult male germ cell tumors.Genes Chromosomes Cancer47(1) , 43–55 (2008).
  • Korkola JE , HouldsworthJ, ChadalavadaRS et al.: Downregulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.Cancer Res.66(2) , 820–827 (2006).
  • Netto GJ , NakaiY, NakayamaM et al.: Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.Mod. Pathol.21(11) , 1337–1344 (2008).
  • Pierce GB : Neoplasms, differentiations and mutations.Am. J. Pathol.77(1) , 103–118 (1974).
  • Kleinsmith LJ , PierceGB Jr: Multipotentiality of single embryonal carcinoma cells. Cancer Res.24 , 1544–1551 (1964).
  • Damjanov I : From stem cells to germ cell tumors and back.Verh. Dtsch. Ges. Pathol.88 , 39–44 (2004).
  • Andrews PW : From teratocarcinomas to embryonic stem cells.Philos. Trans. R. Soc. Lond. B Biol. Sci.357(1420) , 405–417 (2002).
  • Solter D , SkrebN, DamjanovI: Extrauterine growth of mouse egg-cylinders results in malignant teratoma.Nature227(5257) , 503–504 (1970).
  • Mintz B , IllmenseeK: Normal genetically mosaic mice produced from malignant teratocarcinoma cells.Proc. Natl Acad. Sci. USA72(9) , 3585–3589 (1975).
  • Lind GE , SkotheimRI, FragaMF et al.: Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).J. Pathol.210(4) , 441–449 (2006).
  • Honorio S , AgathanggelouA, WernertN et al.: Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.Oncogene22(3) , 461–466 (2003).
  • Kawakami T , OkamotoK, KataokaA et al.: Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas.Genes Chromosomes Cancer38(1) , 97–101 (2003).
  • De Jong J , WeedaS, GillisAJ, OosterhuisJW, LooijengaLH: Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.Oncol. Rep.18(1) , 127–132 (2007).
  • Santagata S , LigonKL, HornickJL: Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.Am. J. Surg. Pathol.31(6) , 836–845 (2007).
  • de Jong J , LooijengaLH: Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future.Crit. Rev. Oncog.12(3–4) , 171–203 (2006).
  • West JA , ViswanathanSR, YabuuchiA et al.: A role for Lin28 in primordial germ-cell development and germ-cell malignancy.Nature460(7257) , 909–913 (2009).
  • Glinsky GV , BerezovskaO, GlinskiiAB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.J. Clin. Invest.115(6) , 1503–1521 (2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.